Filing Details

Accession Number:
0001628280-17-003090
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-30 10:26:48
Reporting Period:
2017-01-03
Filing Date:
2017-03-30
Accepted Time:
2017-03-30 10:26:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1607962 Rewalk Robotics Ltd. RWLK Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661277 Ofir Koren Kochav Yokneam Building, Floor 6
P.o. Box 161
Yokneam Ilit L3 20692
Snr Vp, R&D And Regulatory No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Nis 0.01 Per Share Acquisiton 2017-01-03 500 $1.32 6,565 No 4 M Indirect ESOP
Ordinary Shares, Par Value Nis 0.01 Per Share Disposition 2017-01-03 500 $3.00 6,065 No 4 S Indirect ESOP
Ordinary Shares, Par Value Nis 0.01 Per Share Acquisiton 2017-01-06 4,720 $1.32 10,785 No 4 M Indirect ESOP
Ordinary Shares, Par Value Nis 0.01 Per Share Disposition 2017-01-06 4,720 $3.50 6,065 No 4 S Indirect ESOP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect ESOP
No 4 S Indirect ESOP
No 4 M Indirect ESOP
No 4 S Indirect ESOP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares, Par Value Nis 0.01 Per Share Option (Right to buy) Disposition 2017-01-03 500 $0.00 500 $1.32
Ordinary Shares, Par Value Nis 0.01 Per Share Option (Right to buy) Disposition 2017-01-06 4,720 $0.00 4,720 $1.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,030 2023-07-17 No 4 M Direct
3,310 2023-07-17 No 4 M Direct
Footnotes
  1. Represents the exercise of stock options granted to the reporting person pursuant to the ReWalk 2012 Equity Incentive Plan. The stock options vested and became exercisable in 12 equal quarterly installments starting on August 1, 2014.
  2. Represents an open market sell effected pusuant to a 10B5-1 plan